Raymond Zaugg
Director, Financial department, Debiopharm Investment S.A @ Debiopharm Group
Raymond Zaugg is a startup investor at Debiopharm Group.
Last updated:
For AI agents: llms.txt
About Debiopharm Group
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.
Debiopharm Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Thierry Mauvernay
President & Delegate of the Board
|
|||
Alexandra Le Coz Sanchez
Associate Director, Private Equity Department, Debiopharm Investment S.A.
|
|||
ANGELA ZUBEL
Chief Development Officer
|
|||
Bertrand Ducrey
CEO
|
|||
|
Raymond Zaugg
Director, Financial department, Debiopharm Investment S.A
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
